Performant Healthcare, Inc. (PHLT)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Performant Healthcare (PHLT) Surges 115.2%: Is This an Indication of Further Gains?
Performant Healthcare (PHLT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Performant Healthcare (PHLT) Upgraded to Strong Buy: What Does It Mean for the Stock?
Performant Healthcare (PHLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Performant Healthcare: Guidance Raised After Q1 Outperformance - Buy (Rating Upgrade)
Performant Healthcare reported strong first quarter 2025 results, with revenues and profitability well ahead of consensus expectations. Total healthcare revenues were up by almost 30% on a year-over-year basis, and Adjusted EBITDA increased from ($1.2) million to $3.3 million. With 2025 off to a strong start and considering improving sales and implementation cycles, management raised full-year expectations.
Performant Healthcare, Inc. (PHLT) Q1 2025 Earnings Call Transcript
Performant Healthcare, Inc. (NASDAQ:PHLT ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Jon Bozzuto - Head of Investor Relations Simeon Kohl - Chief Executive Officer Rohit Ramchandani - Chief Financial Officer Conference Call Participants Anderson Schock - B. Riley Securities, Inc. Operator Good afternoon, ladies and gentlemen, and welcome to the Performant Healthcare, Inc., First Quarter 2025 Earnings Conference Call.
Performant Healthcare: Decent Quarter And Guidance But Valuation Remains A Concern - Hold
Performant Healthcare reported Q4/2024 results slightly ahead of expectations. Total healthcare revenues of $34.3 million represented a new high, and the company generated $1.5 million in free cash flow. Despite some expected headwinds this year, management guided for double-digit revenue growth and vastly improved profitability this year. With more recently implemented contracts ramping up to full scale, the company's medium term revenue and profitability targets might be within reach by 2026 and 2027 respectively.
Performant Healthcare, Inc. (PHLT) Q4 2024 Earnings Call Transcript
Start Time: 17:00 January 1, 0000 5:36 PM ET Performant Healthcare Inc. (NASDAQ:PHLT ) Q4 2024 Earnings Conference Call March 12, 2025, 17:00 PM ET Company Participants Simeon Kohl - CEO Rohit Ramchandani - CFO Jon Bozzuto - Head, IR Conference Call Participants Jacob Stephan - Lake Street Capital George Sutton - Craig Hallum Operator Good afternoon, ladies and gentlemen, and welcome to the Performant Healthcare, Inc. Fourth Quarter 2024 Earnings Conference Call. At this time, all lines are in a listen-only mode.
